Jing He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jing He has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Jianxun Ding
Chinese Academy of Sciences
1 shared publication - Jixiu Liu
College of Life Sciences & Health, Wuhan University of Science & Technology, 2 Huangjiahuxi Road, Wuhan, 430065, P. R. China
1 shared publication - Wooram Um
Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan 48513, Republic of Korea
1 shared publication - Yuce Li
College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan 430065, China
1 shared publication
Latest Publications
- 9 October 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19 (29) , 2495-2504
Challenges and opportunities of poly(amino acid) nanomedicines in cancer therapy
Poly(amino acid) nanomedicines hold significant promise for cancer therapy. However, their clinical translation has not matched the extensive efforts of scientists or the burgeoning body of research. The therapeutic outcomes with most nanomedicines often fall short of the promising results observed in animal experiments. This review explores the challenges faced in cancer therapy using poly(amino acid) nanomedicines, particularly addressing the controversies surrounding the enhanced permeability and retention effect and the lack of methods for controlled and reproducible mass production of poly(amino acid) nanomedicines. Furthermore, this review examines the opportunities emerging in this field due to the rapid advancements in artificial intelligence.
- 9 October 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 19 (29) , 2495-2504
Challenges and opportunities of poly(amino acid) nanomedicines in cancer therapy
Poly(amino acid) nanomedicines hold significant promise for cancer therapy. However, their clinical translation has not matched the extensive efforts of scientists or the burgeoning body of research. The therapeutic outcomes with most nanomedicines often fall short of the promising results observed in animal experiments. This review explores the challenges faced in cancer therapy using poly(amino acid) nanomedicines, particularly addressing the controversies surrounding the enhanced permeability and retention effect and the lack of methods for controlled and reproducible mass production of poly(amino acid) nanomedicines. Furthermore, this review examines the opportunities emerging in this field due to the rapid advancements in artificial intelligence.